EFFICACY AND SAFETY OF PALIPERIDONE PALMITATE 3 MONTH FORMULATION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

被引：0

作者：

Berwaerts, Joris ^{[1
]}

Liu, Yanning ^{[2
]}

Gopal, Srihari ^{[1
]}

Nuamah, Isaac ^{[1
]}

Xu, Haiyan ^{[1
]}

Savitz, Adam ^{[1
]}

Coppola, Danielle ^{[1
]}

Schotte, Alain ^{[3
]}

Remmerie, Bart ^{[3
]}

Maruta, Nataliya ^{[4
]}

Hough, David W. ^{[1
]}

机构：

[1] Janssen Res & Dev LLC, Titusville, NJ USA

[2] Johnson & Johnson Med China Ltd, Beijing, Peoples R China

[3] Janssen Res & Dev, Beerse, Belgium

[4] Natl Acad Med Sci Ukraine, Inst Neurol Psychiat & Narcol, Kharkov, Ukraine

来源：

SCHIZOPHRENIA BULLETIN | 2015年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

2087240

引用

页码：S302 / S302

页数：1

共 50 条

[1] Efficacy and Safety of Paliperidone Palmitate 3-month Formulation in Schizophrenia: a Randomized, Double-blind, Placebo-controlled Study
Berwaerts, J.
Liu, Y.
Gopal, S.
Nuamah, I.
Xu, H.
Savitz, A.
Coppola, D.
Schotte, A.
Remmerie, B.
Maruta, N.
Hough, D.
[J]. EUROPEAN PSYCHIATRY, 2015, 30
[2] Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia
Takahashi, Nagahide
Takahashi, Masayoshi
Saito, Takayuki
Iizumi, Misuzu
Saito, Yuki
Shimizu, Hiroko
Matsumura, Taka
[J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1889 - 1897
[3] A randomized, double-blind, placebo-controlled, dose-response efficacy and safety study of paliperidone palmitate in adults with schizophrenia
Pandina, G.
Lindenmayer, J. -P.
Lull, J.
Lim, P.
Gopal, S.
Herben, V.
Kusumakar, V.
Yuen, E.
Palumbo, J.
[J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 232 - 232
[4] Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study
Savitz, Adam J.
Xu, Haiyan
Gopal, Srihari
Nuamah, Isaac
Ravenstijn, Paulien
Janik, Adam
Schotte, Alain
Hough, David
Fleischhacker, Wolfgang W.
[J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 (07):
[5] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RESPONSE STUDY TO ASSESS EFFICACY AND SAFETY OF PALIPERIDONE PALMITATE IN ADULT SUBJECTS WITH SCHIZOPHRENIA
Pandina, Gahan
Lindenmayer, J.
Lull, J.
Lim, P.
Gassmann-Mayer, C.
Yuen, E.
Palumbo, J.
Gopal, S.
[J]. SCHIZOPHRENIA BULLETIN, 2009, 35 : 370 - 370
[6] Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study
Gopal, Srihari
Hough, David W.
Xu, Haiyan
Lull, Julia M.
Gassmann-Mayer, Cristiana
Remmerie, Bart M.
Eerdekens, Marielle H.
Brown, David W.
[J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2010, 25 (05) : 247 - 256
[7] Potential Biomarkers of Impending Schizophrenia Relapse: Exploratory Analysis of a Randomized, Double-Blind, Placebo-Controlled, Phase-3 Study of Paliperidone Palmitate 3-Month Formulation
Gopal, Srihari
Furey, Maura
Hibar, Derrek
Kolb, Hartmuth
Saad, Ziad
Savitz, Adam
Triana-Baltzer, Gallen
[J]. BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S126 - S127
[8] Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study
Kramer, Michelle
Litman, Robert
Hough, David
Lane, Rosanne
Lim, Pilar
Liu, Yanning
Eerdekens, Marielle
[J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (05): : 635 - 647
[9] CETACAINE EFFICACY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
LACHTER, J
JACOBS, R
LAVY, A
SUISSA, A
WEISLER, A
EIDELMAN, S
[J]. GASTROENTEROLOGY, 1988, 94 (05) : A245 - A245
[10] Paliperidone palmitate, an injectable antipsychotic, in prevention of symptom recurrence in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
Hough, David
Gopal, Srihari
Vijapurkar, Ujjwala
Lim, Pilar
Morozova, Margarita
Eerdekens, Marielle
[J]. BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 285S - 286S

← 1 2 3 4 5 →